1. Home
  2. ASMB vs ALUB Comparison

ASMB vs ALUB Comparison

Compare ASMB & ALUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$28.97

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

ALUB

Alussa Energy Acquisition Corp. II Class A Ordinary Shares

N/A

Current Price

$9.98

Market Cap

359.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ASMB
ALUB
Founded
2005
N/A
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.0M
359.7M
IPO Year
2010
2026

Fundamental Metrics

Financial Performance
Metric
ASMB
ALUB
Price
$28.97
$9.98
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$43.40
N/A
AVG Volume (30 Days)
62.5K
13.9K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$274.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.76
$9.91
52 Week High
$39.71
$10.10

Technical Indicators

Market Signals
Indicator
ASMB
ALUB
Relative Strength Index (RSI) 51.90 39.50
Support Level $26.71 $9.97
Resistance Level $30.54 $10.10
Average True Range (ATR) 1.45 0.01
MACD 0.05 -0.01
Stochastic Oscillator 64.01 0.00

Price Performance

Historical Comparison
ASMB
ALUB

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About ALUB Alussa Energy Acquisition Corp. II Class A Ordinary Shares

Alussa Energy Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.

Share on Social Networks: